The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic factor analysis of overall survival (OS) in gastric cancer from two phase III studies of second-line ramucirumab (RAM) (REGARD and RAINBOW) using pooled individual patient (pt) data.
 
Charles S. Fuchs
Consulting or Advisory Role - Acceleron Pharma; Bristol-Myers Squibb; Celgene; Genentech; Lilly; MedImmune; Merck; Momenta Pharmaceuticals; Pfizer; Roche Pharma AG; Sanofi; Takeda; Vertex
 
Kei Muro
Research Funding - Bristol-Myers Squibb; Lilly; Merck
 
Jiri Tomasek
Honoraria - Amgen; Bayer; Lilly; Merck; Roche Pharma AG
Consulting or Advisory Role - Amgen; Ipsen; Roche Pharma AG
Research Funding - Amgen; Lilly; Novartis
Travel, Accommodations, Expenses - Amgen; Novartis; Pfizer; Roche Pharma AG
 
Eric Van Cutsem
Research Funding - amgen (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Lilly (Inst); Merck Serono (Inst); Novartis (Inst); Roche (Inst); Sanofi (Inst)
 
Jae Yong Cho
No Relationships to Disclose
 
Sang Cheul Oh
No Relationships to Disclose
 
Howard Safran
No Relationships to Disclose
 
Gyorgy Bodoky
Consulting or Advisory Role - Bayer; GlaxoSmithKline; Lilly; Novartis; Roche Pharma AG
Speakers' Bureau - Amgen; Bayer; Lilly; Taiho Pharmaceutical
 
Ian Chau
Honoraria - Taiho Pharmaceutical
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Gilead Sciences; Merck Serono; Sanofi
Research Funding - Merck Serono (Inst); Novartis (Inst); Roche Pharma AG (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Sanofi
 
Yasuhiro Shimada
Research Funding - Chugai Pharma; Lilly; Taiho Pharmaceutical
 
Filip Dumitru
No Relationships to Disclose
 
Salah-Eddin Al-Batran
Honoraria - Lilly
Consulting or Advisory Role - Lilly
 
Rodolfo Passalacqua
Honoraria - Lilly; Novartis; Roche Pharma AG
Consulting or Advisory Role - Lilly
Speakers' Bureau - Astellas Pharma
Research Funding - Amgen
 
Atsushi Ohtsu
No Relationships to Disclose
 
Michael Emig
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
David Ferry
Employment - Lilly
Stock and Other Ownership Interests - Lilly
Honoraria - Lilly; Roche Pharma AG; Sanofi
Consulting or Advisory Role - Lilly; Roche Pharma AG; Sanofi
Research Funding - AstraZeneca; Roche Pharma AG; Sanofi
Expert Testimony - Lilly
Travel, Accommodations, Expenses - Roche Pharma AG; Sanofi
 
Kumari Chandrawansa
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Yanzhi Hsu
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Andreas Sashegyi
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Hansjochen Wilke
Honoraria - Lilly
Consulting or Advisory Role - Lilly